Advanced Hormone Receptor Positive (HR+) Breast Cancer
1 clinical trials · Condition
◉ Watch Advanced Hormone Receptor Positive (HR+) Breast Cancer
| Record | Firm | Date |
|---|---|---|
| MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer (NCT05108740) | Novartis Pharmaceuticals |
Track Advanced Hormone Receptor Positive (HR+) Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.